Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
Urologic Oncology|February 19, 2025
Impact of IRAES on the outcomes of pembrolizumab therapy in patients with MUC: A comprehensive analysis of severity and the type and number of affected organsIchiro Yonese, Yosuke Yasuda, Kosuke Takemura, et al.
Japanese Journal of Clinical Oncology|December 16, 2022
Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective studyMotohiro Fujiwara, Minato Yokoyama, Masahiro Toide, et al.
BJU International|May 18, 2018
Computer-aided diagnosis of prostate cancer on magnetic resonance imaging using a convolutional neural network algorithmJunichiro Ishioka, Yoh Matsuoka, Sho Uehara, et al.
Urology|December 7, 2010
A novel repeat biopsy nomogram based on three-dimensional extended biopsyMizuaki Sakura, Satoru Kawakami, Junichiro Ishioka, et al.
Urology|January 30, 2022
Improving Accuracy, Reliability, and Efficiency of the RENAL Nephrometry Score With 3D Reconstructed Virtual ImagingKasumi Kaneko Yoshitomi, Yoshinobu Komai, Tatsuya Yamamoto, et al.
International Journal of Clinical Oncology|June 12, 2021
External validation of the Briganti 2019 nomogram to identify candidates for extended pelvic lymph node dissection among patients with high-risk clinically localized prostate cancerEri Fukagawa, Shinya Yamamoto, Sachiko Ohde, et al.
International Urology and Nephrology|March 27, 2013
Diagnostic performance of initial transperineal 14-core prostate biopsy to detect significant cancerHideki Takeshita, Noboru Numao, Toshiki Kijima, et al.
The Journal of Urology|March 12, 2013
Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancerNoboru Numao, Soichiro Yoshida, Yoshinobu Komai, et al.
Cancer Immunology, Immunotherapy : CII|September 3, 2020
Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumabToshiki Kijima, Hina Yamamoto, Kazutaka Saito, et al.
Japanese Journal of Clinical Oncology|March 12, 2026
Real-world insights from comprehensive genomic profiling in patients with metastatic castration-resistant prostate cancerYosuke Yasuda, Soichiro Yoshida, Sadakatsu Ikeda, et al.
Pageof 13